3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Suspended
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Carcinoma, Non-Small-Cell Lung
44
Colorectal Neoplasms
22
Breast Neoplasms
22
Stomach Neoplasms
21
Neoplasms
18
Esophageal Squamous Cell Carcinoma
12
Neoplasm Metastasis
11
Nasopharyngeal Carcinoma
11
Lung Neoplasms
11
Rectal Neoplasms
9
Colonic Neoplasms
8
Pancreatic Neoplasms
7
Uterine Cervical Neoplasms
6
Esophageal Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Ovarian Neoplasms
5
Osteosarcoma
5
Brain Neoplasms
5
Small Cell Lung Carcinoma
4
Recurrence
4
Glioblastoma
4
Gastrointestinal Neoplasms
4
Precision Cell Immunotherapy
3
Melanoma
3
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Head and Neck Neoplasms
3
Gastrointestinal Diseases
3
Digestive System Neoplasms
3
Carcinoma, Ovarian Epithelial
3
Interventions
Cyclophosphamide
5
fludarabine
4
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
3
Gemcitabine
3
fludarabine phosphate
2
endostar protein
2
Melphalan
2
Etoposide
2
Doxorubicin
2
Cisplatin
2
Alemtuzumab
2
thymoglobulin
1
spartalizumab
1
selinexor
1
pembrolizumab
1
Vindesine
1
Vincristine
1
Sensitivity and Specificity
1
Rituximab
1
Prednisone
1
Prednisolone
1
Methylprednisolone
1
Interleukin-2
1
Flavin-Adenine Dinucleotide
1
Epirubicin
1
Endostatins
1
Drug Therapy
1
Dexamethasone
1
Cytarabine
1
Clinical Protocols
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Lymphoma, T-Cell
×
Drug Therapy
×
Clear all
NCT00725231
2012-05-07
A-CHOP-14
University of Göttingen
Phase 3
Unknown
274 enrolled